Literature DB >> 3631390

Prospective comparison of noninvasive techniques for amputation level selection.

J M Malone, G G Anderson, S G Lalka, R M Hagaman, R Henry, K E McIntyre, V M Bernhard.   

Abstract

This study prospectively compared the following tests for their accuracy in amputation level selection: transcutaneous oxygen, transcutaneous carbon dioxide, transcutaneous oxygen-to-transcutaneous carbon dioxide, foot-to-chest transcutaneous oxygen, intradermal xenon-133, ankle-brachial index, and absolute popliteal artery Doppler systolic pressure. All metabolic parameters had a high degree of statistical accuracy in predicting amputation healing whereas none of the other tests had statistical reliability. Amputation site healing was not affected by the presence of diabetes mellitus nor were the test results for any of the metabolic parameters.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3631390     DOI: 10.1016/0002-9610(87)90174-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

Review 1.  Selection of level for lower limb amputation in patients with severe peripheral vascular disease.

Authors:  C A Clyne
Journal:  Ann R Coll Surg Engl       Date:  1991-05       Impact factor: 1.891

2.  Transmetatarsal amputation: an 8-year experience.

Authors:  S R Thomas; J M Perkins; T R Magee; R B Galland
Journal:  Ann R Coll Surg Engl       Date:  2001-05       Impact factor: 1.891

3.  Predictive value of 99mTc-sestamibi scintigraphy for healing of extremity amputation.

Authors:  Ali Sarikaya; Husamettin Top; A Cemal Aygit; Erol Benlier; Yasin Unal
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-29       Impact factor: 10.057

4.  Ischemic Muscle Necrosis of Lower Extremities in Peripheral Arterial Disease: The Impact of 99mTc-MDP Scintigraphy on Patient Management.

Authors:  Donatas Jocius; Donatas Vajauskas; Arminas Skrebunas; Marijus Gutauskas; Algirdas Edvardas Tamosiunas
Journal:  Medicina (Kaunas)       Date:  2019-11-28       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.